 propranolol propranolol portal hypertens cirrhosi studi object propranolol reduc hepat portal pressur patient cirrhosi design random trial patient fifti patient cirrhosi esophag varic studi intervent twenty-on patient oral propranolol dose rest heart rate patient oral propranolol schedul oral mg day measur hepat vein pressur gradient liver function splanchnic system hemodynam month continu therapi main result month hepat venou pressur gradient patient propranolol mm Hg CI mm Hg mm Hg CI mm Hg hepat venou pressur gradient baselin valu patient propranolol patient therapi signific decreas hepat blood flow intrins clearanc indocyanin green propranolol therapi therapi treatment similar reduct azygo blood flow cardiac output conclus long-term combin administr propranolol reduc portal pressur advers effect hepat perfus liver function hemodynam effect clinic efficaci control trial